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13 as well as components of the innate stress response, including
the chi-lectins Chi3L1 and Chi3L2 and complement component
C3. The major cytokines present were IL-6, GRO, Rantes and
MCP-1. Neither IL-1 nor TNF-α was detectable. Several stress
response proteins, such as the complement components C1r, C1s
and factor H, clusterin, nucleobindin, the chi-lectin Chi3L1 and
EDA-domain containing ﬁbronectin were detectable both in control
media and following activation of TLR2. Peptidoglycan, TNF-α and
IL-1 induced secretion of Chi3L2, the second member of the hu-
man chi-lectin family. Chi3L2 was not detectable in control media.
Both Chi3L1 and Chi3L2 were present in cartilage from asymp-
tomatic individuals. In contrast to Chi3L1, Chi3L2 levels correlated
with the presence of macroscopic signs of damage (Fig. 1).
Figure 1. Expression of Chi3L1 and Chi3L2 in articular cartilage from femoral
heads of patients undergoing joint replacement. Protein levels were determined
by western blotting using speciﬁc antisera. The intensity of bands was deter-
mined densitometrically and normalized to a Chi3L1 or Chi3L2 standard in-
cluded in each blot. Cartilage specimens are grouped into those showing macro-
scopic lesions and lesion-free specimens. The lines represent the mean for each
data set.
Conclusions: The increased production of stress response pro-
teins associated with tissue repair and wound healing by chon-
drocytes suggests that they attempt a repair response similar to
that described in other connective tissues. The induction of the
chi-lectin Chi3L2 is part of this stress response. Its presence in
articular cartilage with early signs of degeneration suggests that
Chi3L2 is produced in response to changes in the matrix environ-
ment and thus could be a useful indicator for the diagnosis and
progression of cartilage erosion.
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Purpose: Our previous study demonstrated that partial inactivation
of Pitx1 gene led to a progressive formation of OA-like lesions in
aging Pitx1+/- mice. To investigate whether Pitx1 plays a role in
human osteoarthritis pathogenesis, we analyzed the expression
level of Pitx1 in knee cartilage of OA patients and age- and gender-
matched control subjects. We observed that Pitx1 mRNA and
protein levels were signiﬁcantly down-regulated in OA patients.
The goals of this study are: 1) to elucidate the mechanisms
responsible for the down-regulation of Pitx1 in osteoarthritis and
2) to identify genes affected by the loss of Pitx1.
Methods: To look for possible mutations, genomic DNA from OA
patients and normal subjects were isolated and 10 kb fragment
upstream of Pitx1 initiation transcription site was sequenced. A
region in Pitx1 promoter, where a SNP was found in the core of an
E2F-response element, was used as bait for DNA pull-down assay
followed by mass spectrometry analysis. The proteins which were
identiﬁed by this method were challenged in different assays either
to conﬁrm their presence in the protein-DNA complex (by EMSA,
ChIP and co-immunoprecipitation), to analyze their expression
level (by RT-PCR and immunohistochemistry) or to determine their
ability to affect the regulation of Pitx1 (by transfection assays
with luciferase). Finally, to identify potential transcriptional targets
of Pitx1, expression level of candidate genes were analysed by
RT-PCR using either mouse model or mRNA isolated from normal
and OA chondrocytes.
Results: No mutation was found in human Pitx1 promoter to
be signiﬁcantly associated with osteoarthritis. Nevertheless, a
SNP, which was found in an E2F-response element caught our
attention since E2F1 was known to up-regulate Pitx1. The mass
spectrometry analysis allowed us to identify a repressor complex
constituted of PHB1, PHB2 and BCoR, which are also known to
act as co-repressors. The presence of BCoR tethered to this E2F
response element was demonstrated by EMSA and ChIP assays.
Since BCoR has never been shown to form a complex with PHB1,
we conﬁrmed this result by co-immunoprecipitation using nuclear
extracts from chondrocytes of OA patients. By transfection assays
using luciferase reporter gene, we were able to show that the
complex formed of PHB1, PHB2 and BCoR is functionally capable
of down-regulating the expression of Pitx1. Using mRNA isolated
from Pitx1+/+, Pitx1-/- mice and OA patients, we were able to
show that knockdown of Pitx1 expression resulted in up-regulation
of PPAR-gamma, Parp1, Extl3 and Reg1B.
Conclusions: We discovered a new complex formed of PHB1,
PHB2 and BCoR which are tethered to an E2F-response element
and able to down-regulate the expression of Pitx1 in chondrocytes
of OA patients. In pre-OA chondrocytes, the nuclear accumulation
of PHB1 could be a primary mechanism leading to OA onset.
The subsequent loss of Pitx1 expression could contribute to the
progression of OA via the up-regulation of PPAR-gamma, Parp1,
Extl3 and Reg1B.
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Purpose: ADAMTS4 and ADAMTS5 are accepted as the main
aggrecanases involved in OA cartilage degradation but the rela-
tive contribution of each enzyme in human disease is still under
debate. Mouse knockout studies have conﬁrmed the importance
of ADAMTS5 in cartilage degradation while ADAMTS4 is generally
associated to OA due to its strong upregulation by IL1β. SiRNA ex-
periments indicate that both aggrecanases participate in cartilage
degradation in human explants. The present study seeks to further
elucidate the role of both aggrecanases in cartilage degradation
using selective pharmacological inhibitors.
Methods: Induction of ADAMTS4 and ADAMTS5 expression by
different cytokines was studied in cartilage explants using RT-
QPCR. Cartilage degradation was induced in human explants
by OSM+TNFα or OSM+ IL1β and the role of individual aggre-
canases was evaluated by pharmacological inhibition using com-
pounds which were synthesised and selected for high selectivity
for ADAMTS4 or ADAMTS5.
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Aggrecanase activity was assessed by measuring in the gly-
cosaminoglycan (GAG) release and ARGSVIL neoepitope forma-
tion. Explants were further examined by histology after safranin
O proteoglycans (PG) staining/light green counterstaining, and by
immunohistochemistry for aggrecan NITEGE neoepitope. PG and
neoepitope content was then quantiﬁed applying a scoring system
to individual images.
In addition, cytokine-induced matrix degradation was assessed
in a new rat chondrosarcoma cell model (‘RCS assay’) in which
the amount of sulphated proteoglycan was quantiﬁed using Alcian
blue staining and image processing.
Results: TNFα+OSM or IL1β+OSM strongly induced ADAMTS4
and ADAMTS5 in human cartilage explants. OSM is strictly needed
for induction of aggrecanases but not for MMP13.
A speciﬁc ADAMTS5 inhibitor (cpd A, IC50 80% inhibition of GAG
release, >80% inhibition of neoepitope release at 3μM). In con-
trast, a selective ADAMTS4 inhibitor (cpd B, IC50 <100 nM) did
not inhibited cartilage degradation by more than 50%. Cpd C,
a non-selective 3-OH-3-methylpipecolic hydroxamate type metal-
loproteinase inhibitor completely inhibited GAG and Neoepitope
release.
Histological evaluation conﬁrmed that cpd A prevented PG loss
and inhibited neoepitope formation in cartilage matrix but not in
the pericellular matrix (PM), while cpd B only inhibited neoepi-
tope formation in PM. Cpd C prevented PG loss and inhibited
neoepitope formation in both cartilage matrix and PM.
In addition, the compound ranking obtained in the explant model
was reproduced with the simple ‘RCS assay’.
Conclusions: This study represents the ﬁrst pharmacological ev-
idence for the importance of ADAMTS5 over ADAMTS4 in human
cartilage degradation. Strong induction of ADAMTS5 by cytokines
and signiﬁcant prevention of cartilage degradation by its pharma-
cological inhibition using a selective inhibitor are demonstrated.
This observation underscores the important role of ADAMTS5 in
the degradation of human cartilage. Furthermore, these ADAMTS5
effects were recapitulated in a new RCS-based assay, which
provides a good substitute for the complex cartilage explant
model.
Finally, histological analysis delivered the unexpected observation
that matrix aggrecan is subject to different proteolytic events
depending on its localization, providing mechanistic information
on the cartilage degradation process.
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Purpose: Melanocortins (MCs) are structurally related peptides
that elicit their actions via binding to melanocortin receptors (MC-
Rs). Originally deﬁned as neurohormones these peptides exhibit
an astonishing spectrum of effects on many peripheral cell types
and tissues. However, our present knowledge on the function of
the MC system in cartilage is scarce. We could show that MC-
1R is expressed in human articular cartilage and chondrocytes.
α-Melanocyte-stimulating hormone (α-MSH), a prototype of MCs,
is capable of regulating a number of important genes involved
in extracellular matrix (ECM) composition and inﬂammation in
chondrocytes. The major goal of this study is to deﬁne the role of
MCs and the MC-1R in the context of osteoarthritis (OA).
Methods: Cartilage slices were aseptically dissected from femoral
condyles of OA patients who underwent total knee arthroplasty. Ar-
ticular chondrocytes isolated from OA-cartilage were proliferated in
monolayer until passage one and either cultured in 3D-micromass
pellets for 7 days or kept in monolayer. After stimulation for 48h
with 10-6 M α-MSH only (micromass pellet culture) or in pres-
ence of 1 ng/ml IL-1β (monolayer culture); the cDNA copy number
of Sox9, collagens, MMPs; TGF-β1,TNF-α and interleukins was
assessed with quantitative RT-PCR. POMC, converting enzymes
and MC-receptor gene expression was determined by end point
RT-PCR and, MC-R1 protein expression in situ on cryosections
of OA-cartilage by immunohistochemistry. Signal transduction of
α-MSH was evaluated by cAMP ELISA and Ca2+-assays using
Fura2-AM. Protein concentration of MMP-2, MMP-13, IL-6, TNF-α,
TGF-β1 and collagen I and II in cell culture supernatants and cell
lysates was determined with ELISA.
Results: Articular OA-chondrocytes express receptors MC-1R,
MC-2R and MC-5R plus POMC and converting enzymes PC1,
PACE4 and furin convertase. MC-1R protein was preferentially
found on chondrocytes from the middle and deep zones of articular
cartilage. The MC-1R detected in human chondrocytes appears to
be functional as stimulation with 10-6 M α-MSH resulted in a mod-
erate but signiﬁcant increase in intracellular cAMP levels but not in
changes of the intracellular Ca2+ level. In vitro application of 10-6 M
α-MSH to articular chondrocytes, kept in micromass pellet culture
induced gene expression of COL1A1, COL2A1 and COL10A1. Of
note, gene expression of MMP-2, MMP-7, MMP-9 and MMP-13
was induced, however, MMP-13 protein concentrations in culture
supernatant revealed profound interpatient ﬂuctuations. MMP-2
protein concentration was consistent within the sample collective
and remained unaltered in the presence of α-MSH. IL-1β and TNF-
α gene expression was reduced, IL-6 remained mostly unchanged
and Sox9 and TGF-β1 were induced upon stimulation with α-MSH.
IL-6 and TNF-α protein concentration were upregulated. α-MSH
attenuates IL-1β-induced expression of IL-4 and IL 8, MMP-2, -9
and -13 in articular OA-chondrocytes.
Conclusions: Human articular chondrocytes are target cells for
α-MSH. The effects of α-MSH on cytokine- and MMP expres-
sion suggest a chondroprotective role of this neuropeptide in
inﬂammatory and degenerative processes in cartilage. It is con-
ceivable that inﬂammatory reactions can be mitigated by induction
of endogenous melanocortins or administration of α-MSH to the
affected joints. The induction pattern of regulatory and structural
ECM components as collagens, Sox9, anabolic and catabolic cy-
tokines points towards a function of α-MSH as a trophic factor
in skeletal development during endochondral ossiﬁcation or as
anti-inﬂammatory agent in degenerative joint pathologies.
224
THE FUNCTION OF p53 ON HUMAN CHONDROCYTE
APOPTOSIS IN RESPONSE TO SHEAR STRESS
S. Hashimoto, T. Nishiyama, S. Hayashi, K. Takebe, N. Kanzaki,
T. Fujishiro, R. Kuroda, M. Kurosaka
Kobe Univ. Hosp., Kobe, Japan
Purpose: Chondrocyte apoptosis plays an important role in carti-
lage degeneration in osteoarthritis (OA), and mechanical injury to
cartilage induces chondrocyte apoptosis. p53 has been identiﬁed
as a 53 kDa cellular protein and ‘ultimate tumor suppressor gene’.
p53 is recognized as a pivotal regulatory protein that responds to a
variety of signals and recruits an array of biochemical activities to
trigger diverse biological responses, most notably cell cycle arrest
and apoptosis. In response to DNA damage, p53 expression is up-
regulated, increases transcriptional activity, and initiates apoptosis
signals. p53-regulated apoptosis-inducing protein 1 (p53AIP1) is
one of the p53-regulated genes, and is activated in response to
severe DNA damage with the phosphorylation of p53 at Ser-46.
In this study, we speculated that p53 and p53AIP1 might play an
important role in DNA damage-induced apoptosis of articular carti-
